Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
It stimulates fibroblasts and signaling pathways throughout the dermal and subdermal layers, not just at the needle-channel entry points
It is intended for research applications, often in academic or clinical settings exploring the peptides effect on neurotransmitter levels, stress, and chronic pain
DAILY USE WITH NO RESIDUE: Spray directly onto the scalp once daily and massage gently
Safety Considerations and Possible Side Effects B12 is generally safe, but there are some side effects and safety issues to watch out for
If medical approval is denied you will be refunded automatically
